CardioComm Solutions, Inc.
EKG.V
TSX
| Weiss Ratings | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.53 | |||
| Price History | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -25.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | -40.00% | |||
| Year to Date Total Return | 50.00% | |||
| 1-Year Total Return | 50.00% | |||
| 2-Year Total Return | -25.00% | |||
| 3-Year Total Return | -57.14% | |||
| 5-Year Total Return | -57.14% | |||
| 52-Week High % Change | -60.00% | |||
| 52-Week Low % Change | 100.00% | |||
| Price | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.03 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | Mar 15, 2024 | |||
| 52-Week High Price (Date) | Oct 01, 2024 | |||
| Valuation | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.34M | |||
| Enterprise Value | 1.46M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | 166.67% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 5.00 | |||
| Price/Book (Q) | -14.29 | |||
| Enterprise Value/Revenue (TTM) | 3.74 | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -6.42 | |||
| Enterprise Value/EBIT | -6.38 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 188.97M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 977 9425 | |||
| Address | 18 Wynford Drive Toronto, ON M3C 3S2 | |||
| Website | cardiocommsolutions.com | |||
| Country | Canada | |||
| Year Founded | 1989 | |||
| Profitability | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -58.62% | |||
| Profit Margin | -35.33% | |||
| Management Effectiveness | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -54.27% | |||
| Return on Equity | -- | |||
| Income Statement | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 390.60K | |||
| Total Revenue (TTM) | 390.60K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 368.10K | |||
| EBITDA (TTM) | -227.40K | |||
| EBIT (TTM) | -229.00K | |||
| Net Income (TTM) | -138.00K | |||
| Net Income Avl. to Common (TTM) | -138.00K | |||
| Total Revenue Growth (Q YOY) | -45.31% | |||
| Earnings Growth (Q YOY) | -154.71% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -200.00% | |||
| Balance Sheet | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 57.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 199.20K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -136.10K | |||
| Current Ratio (Q) | 0.556 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 246.10K | |||
| Total Current Liabilities (Q) | 358.00K | |||
| Total Debt (Q) | 183.20K | |||
| Total Liabilities (Q) | 382.30K | |||
| Total Common Equity (Q) | -136.10K | |||
| Cash Flow | EKG.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.50K | |||
| Cash from Financing (TTM) | 32.50K | |||
| Net Change in Cash (TTM) | 19.50K | |||
| Levered Free Cash Flow (TTM) | -110.20K | |||
| Cash from Operations (TTM) | -11.60K | |||
